JD, I think the big question once we get the RD news (assuming positive news) is whether an RD pharma deal can be finalized prior to Cortex having to do a financing. A small interim financing after good RD news wouldn't be so bad, in comparison to where the pps is now. But instead, a pharma deal for RD might be consummated, say within a month or two of the RD results. Cortex's cash position doesn't drop to the $5 mil range until approx late October (see cash projections below), so that gives August and September to finalize the RD deal.
Aug - 8.0 mil
Sep - 6.8 mil
Oct - 5.6 mil
Nov - 4.5 mil
Cortex has undoubtedly already had some discussions with various pharmas who are interested in RD, pending the trial results, so it's conceivable that a deal might be inked by Aug/Sept.
Alternately, Cortex could do a modest interim financing for say $5 mil (as was done in early 2007), ie - just enough to get by until the RD deal is finalized.